Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.
Conditions: Hepatitis C Chronic; Hepatitis C Interventions: Other: standard of care Sponsors: Hospital El Cruce; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Feasibility and Acceptability of HCV Treatment in Pregnancy
Conditions: Hepatitis C; Pregnancy Complications Interventions: Drug: Glecaprevir-pibrentasvir Sponsors: Washington University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites
Conditions: Hepatitis B; Hepatitis B Infection Interventions: Device: iStatis HBsAg Test Sponsors: bioLytical Laboratories; St Vincent ' s Hospital Melbourne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
Conditions: Hepatitis B; Hepatitis B Infection Interventions: Device: iStatis HBsAg Test Sponsors: bioLytical Laboratories Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease （OCEAN PROJECT）
Conditions: Nonalcoholic Fatty Liver Disease; Chronic Hepatitis b Interventions: Drug: Peg-Interferon α Sponsors: First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users
Conditions: Hepatitis C Interventions: Device: INSTI HCV Self Test Sponsors: bioLytical Laboratories Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Conditions: Chronic Hepatitis B Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo 10mg Tab Sponsors: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus
Conditions: Hepatitis B; Hepatitis D; Viral Hepatitis Interventions: Diagnostic Test: investigations for Hepatitis D virus Sponsors: National Center for Gastroentestinal and Liver Disease Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Complex Exploratory Study of Alcohol-Associated Hepatitis
Conditions: Alcoholic Hepatitis Sponsors: Pavol Jozef Safarik University; L Pasteur University Hospital; Hospital Agel Kosice-Saca; Technical University in Kosice; Western University; University of Roma La Sapienza Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
Conditions: Autoimmune Hepatitis Sponsors: Beijing Friendship Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
INSTI ® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
Conditions: Hepatitis C Interventions: Device: INSTI HCV Self Test Sponsors: bioLytical Laboratories Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
The Treatment of PD-1 Antibody Combined With Peg-IFN α in NAs-suppressed CHB Patients
Conditions: Chronic Hepatitis B Interventions: Drug: Sintilimab; Drug: Peg-IFN α-2b; Drug: NAs Sponsors: Beijing 302 Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function
Conditions: Alcoholic Hepatitis Interventions: Biological: Plasma Exchange; Other: Standard Medical Treatment Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Re-link HCV in Substance-Use Telemedicine Program
Conditions: Hepatitis C Interventions: Behavioral: Re-Link Sponsors: trueNorth Medical Centres; Gilead Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.
Conditions: Occult Hepatitis B in Cancer Patients Interventions: Other: Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
